New Mexico
The New Mexico Board of Pharmacy rules now allow Certified Immunization Pharmacy Technicians to vaccinate ALL vaccines to anyone prescribed by their Supervising Pharmacist, effective November 30, 2021.
Also in New Mexico, Gov. Michelle Lujan Grisham (D) extended the Public Health Order requiring masks indoors in all public settings through January 7th, 2022.
For more information, contact NACDS' Mary Staples at 817-308-2103.
North Carolina: The North Carolina Board of Pharmacy published proposed administrative rules concerning pharmacy interns. These rules can be found beginning on Page 1049 (PDF Page 57) of the North Carolina Register.
The Board will hold a public hearing on these rules on February 8, 2022. The public hearing will be held remotely. The public can participate on Teams at https://tinyurl.com/jsuk4bjk or call 336-604-5350, conference ID 903 191 899#. The Board will accept written comments until February 14, 2022, and should be submitted to Jay Campbell, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517; fax (919) 246-1056; email ncboprulemaking@ncbop.org.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
North Carolina
The North Carolina Board of Pharmacy published proposed administrative rules concerning pharmacy interns. These rules can be found beginning on Page 1049 (PDF Page 57) of the North Carolina Register.
The Board will hold a public hearing on these rules on February 8, 2022. The public hearing will be held remotely. The public can participate on Teams at https://tinyurl.com/jsuk4bjk or call 336-604-5350, conference ID 903 191 899#. The Board will accept written comments until February 14, 2022, and should be submitted to Jay Campbell, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517; fax (919) 246-1056; email ncboprulemaking@ncbop.org.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
North Dakota
The Health Care Committee announced a meeting on December 16 and posted an agenda including the Medication Optimization Study and the Prescription Drug Study.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
The Board of Pharmacy adopted the following permanent rules effective last Friday, December 10.
- OAR 855-006-0005 related to Definitions
- OAR 855-007-0088 related to Compliance with OHA COVID Rules
- OAR 855-020-0110 and OAR 855-020-0300 related to Pharmacist Prescriptive Authority- COVID mAb, PEP & PrEP
Also in Oregon, the Board of Pharmacy adopted the following temporary rules effective last Friday, December 10.
- OAR 855-006-0005 related to Definitions
- OAR 855-020-0300 related to Pharmacist Prescriptive Authority: COVID-19 Antigen Self-Test
- OAR 855-041-1092 related to Temporary Pharmacy Closures
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Rhode Island
On Wednesday, December 15th ,Governor McKee held a news conference to announce that he will be instituting several COVID mitigation measures, one being a modified mask mandate, in Rhode Island. If the space can hold 250 or more, masks will be required, under 250, masks or proof of vaccine will be required. See the official Executive Order. These temporary measures will take effect on Monday, December 20, 2021.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Utah
The Division of Occupational and Professional Licensing published a proposed rule to implement SB 177 and HB 178 enacted earlier this year, to amend the rule in accordance with Executive Order 2021-12 and to make changes consistent with Office of Administrative Rule's current Rule Writing Manual. The deadline for written comments is January 14, 2022. Below is an outline of the various proposed amendments:
- Section R156-17b-102: to add definitions for "consulting pharmacist," "designated representative," and "responsible individual," and clarify that compounding as defined in Section 58-17b-102(18) does not include adding flavoring agents to conventionally manufactured and commercially available liquid medication if the flavoring agents are therapeutically inert and do not exceed five percent of a preparation's total volume.
- Sections R156-17b-601 and R156-17b-612: permits a pharmacy technician or pharmacy intern to transfer a legend prescription and permit dispensing of emergency prescriptions.
- Section R156-17b-603: to require a consulting pharmacist, PIG, RDPIC, or DMPIC to complete a self-audit after certain changes and prior to the end of a renewal cycle.
- Section R156-17b-614a: to clarity that the pharmacy department shall be equipped with a lock where drugs are stored.
- Section R156-17b-621a: to delete the continuing education requirement for pharmacists engaging in the administration of long-acting injectable drugs.
Also, the addition of Section R156-17b-627 defines operating standards for a pharmacist prescribing prescription drugs or devices.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Alabama
Pharmacy Technicians don't forget to renew your license with the Alabama Board of Pharmacy. Technicians' licenses expire Dec. 31, 2021. If you fail to renew your license by that date, but continue to work as a pharmacy technician, you will be subject to late fees and discipline. For more information, please contact the Board of Pharmacy directly 205-981-2280. Pharmacy permits must be renewed prior to December 31, 2021, as well. Renewals may be completed ONLINE ONLY. Visit www.albop.com for both types of renewal.
Also in Alabama, the Alabama Medicaid Agency relocated the Birmingham District Office to the Beacon Ridge Tower (600 Beacon Parkway West, Suite 105, Homewood, Alabama) on Wednesday, December 1, 2021.
Finally, in Alabama, Medicaid continues to monitor the COVID-19 national emergency in and is adding procedure codes for coverage of COVID-19 Monoclonal Antibody Infusion.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Arkansas
Prior to the adjournment of the three-day special session that Gov. Asa Hutchinson (R) convened December 6th, both houses approved legislation repealing the Insulin Rebate law passed during the regular session earlier this year. Gov. Asa Hutchinson (R) signed the bills into law – SB7- Act9 and HB1005- Act 13 on December 9th.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
California
The Medi-Cal Rx Web Portal has been updated with the following:
- Medi-Cal Rx Web Claims Submission (WCS) User Guide. More information on User Administration Console (UAC) registration is available in the UAC Quick Start Guide.
- Countdown to Go-Live — Are You Aware of the Cutoff Dates? includes important information and deadlines leading up to implementation of Medi-Cal Rx, effective January 1, 2022.
Also in California, for Medi-Cal Rx updates, please visit the Department of Health Care Services' Medi-Cal Rx: Transition website and the Medi-Cal Rx website. Medi-Cal Rx pharmacy stakeholders are strongly encouraged to sign-up for urgent announcements and other updates as they are posted to the Medi-Cal Rx website. Medi-Cal Rx will be effective January 1, 2022.
Also in California, the Board of Pharmacy released the following Notices of Modified Text:
- Further amending section 1715.6 to Title 16 of the California Code of Regulations related to Reporting Drug Losses.
- Further amending section 1715.65 to Title 16 of the California Code of Regulations related to Inventory Reconciliation.
Comments are due December 18 and can be submitted to Lori Martinez .
Finally in California, This is a reminder that under SB 212 (2018), which established a prescription drug and sharps take-back program in California, retail pharmacies that sell a covered drug under their own label must submit written notification to the Board of Pharmacy identifying the covered entity from which the retail pharmacy obtains the covered product.
"Covered entity" is defined under SB 212 as a manufacturer of covered products that are sold into the state. If there is not a manufacturer for a covered product, then the covered entity is the distributor of the covered product sold into the state. If there is not a manufacturer or distributor for a covered product, then the covered entity is the owner or licensee of a trademark or brand name under which covered products are sold into the state. If there is not a manufacturer, distributor, or owner or licensee of trademark or brand name, then the covered entity is the importer of the covered product into the state.
Please click here to view the relevant provision in statute – Public Resources Code Section 42031(b).
We have been made aware that few pharmacies required to report this information have not done so. If applicable, this is a reminder to please submit this information to the Board of Pharmacy's Executive Officer, Anne Sodergren, at anne.sodergren@dca.ca.gov and lilly.fang@dca.ca.gov.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Colorado
The Department of Health Care Policy and Financing (HCPA) issued an Operational Memo informing Health First Colorado (Medicaid) providers of their obligation to effectively communicate coordination of benefits requirements to Health First Colorado members who have primary third party insurance.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
District of Columbia
The Department of Health approved a final rule requiring reporting of vaccines by all providers, including pharmacies, with 24 hours of vaccine administration to the registry. The rule will be effective when published in the DC Register.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Florida
Rule 64B16-28.108 related to labeling of Medicinal Drugs by pharmacy permits has been revised by the Board of Pharmacy and became effective November 28, 2021. The revision is primarily for Institutional Class II, Modified Class II Type B, or Class III permits that are labeling patient specific medications.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Georgia
The Department of Public Health would like to hear from pharmacies who may be interested in providing the FDA approved COVID-19 therapeutic pill, Molnupiravir. Please take a minute to complete this COVID-19 Molnupiravir Pharmacy Interest Survey.
If you would like to learn more about Merck's Molnupiravir pill, CLICK HERE to watch a 30-minute presentation by Lisley Brooks B.S., Doctor of Pharmacy Candidate 2022 and Tracy Dabbs, PharmD, Georgia Department of Public Health.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Iowa
On December 6, the Board of Pharmacy transitioned to a new payment platform (Gov2Go) for online applications. Additional information about the Iowa eGovernment portal, Gov2Go, was posted later this week. For faster access to Gov2Go, please create a Gov2Go account at web.gov2go.com. If you experience any payment issues while applying for a new license/registration or renewing an existing license/registration, please contact Terry Witkowski.
Also in Iowa, the Department of Public Health (IDPH) posted a NEW Vaccine Information Brief (12.10.21) with update on the vaccine allocation survey on December 13 that will not include Pfizer Adolescent/Adult Vaccine in order to utilize existing inventory in the state and FDA expands eligibility for Pfizer-BioNTech COVID-19 Booster Dose to Individuals 16 and 17 years of age. Also note last week's Vaccine Information Brief (12.3.21) announcing ACIP COVID-19 Vaccine Booster Recommendation, Moderna Shelf-Life Extension Update and Updated – Interim Clinical Considerations for Use of COVID-19 Vaccines and this week's Vaccine Information Brief (12.8.21) with information about Pfizer transition to Comirnaty. Please direct questions to the COVID-19 Vaccine Call Center at 1-800-831-6293 ext. 1 or email.
Also in Iowa, the Department of Human Services, Iowa Medicaid Enterprise, issued INFORMATIONAL LETTER NO. 2295-MC-FFS announcing the alignment between Managed Medicaid and Medicaid Fee-for-Service to limit the number of diabetic needles that member may obtain per month. The managed care organizations currently allow 100 needles per month. Members enrolled in Medicaid Fee-for-Service were also be limited to 100 diabetic needles per month effective December 1, 2021.
Finally in Iowa, the Department of Human Services, Iowa Medicaid Enterprise, issued INFORMATIONAL LETTER NO. 2291-MC-FFS announcing several Medicaid Pharmacy Program Changes effective January 1, 2022, related to the following:
- Changes to the Preferred Drug List (PDL);
- Pharmacy benefit policy changes for albumin human, papaverine injection solution and Zoladex subcutaneous implant;
- New Drug Prior Authorization (PA) Criteria for non-biologic agents for ulcerative colitis, Vericiguat (Verquvo) and Viloxazine (Qelbree)
- Changes to Existing PA Criteria for Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist, Oral [formerly Elagolix Products], Omalizumab (Xolair) and Topical Acne and Rosacea Products
- Point of Sale Billing Updates (ProDUR Quantity Limits) and
- DUR Update
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Kentucky
The Board of Pharmacy approved an emergency amendment to the pharmacy closure regulation at its Nov. 30 meeting. As an emergency regulation, once it is filed with the LRC it will be in effect immediately. The regulation changes the temporary pharmacy closure notification requirement from 5 days to 2 two days within a 14-day period or 9 days in a 30-day period and requires pharmacies to notify the board in immediately in writing of a closure meeting the threshold. Additionally, it has requirements for signage, control of prescriptions, notification of providers and post-closure claims adjudication.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Missouri
The Department of Commerce and Insurance (DCI) Board of Pharmacy issued a bulletin on Vaccine Provider Healthcare Assistance in response to the Board of Pharmacy received regarding if pharmacies can use non-pharmacy healthcare providers to help provide both COVID-19 and non-COVID-19 vaccines.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Nebraska
The Department of Health and Human Services announced the next COVID-19 Medicaid Provider call will take place on December 15 at noon (Central).
Also in Nebraska, the Department of Health and Human Services (DHHS) updated the Janssen COVID-19 Vaccine Administration – Booster – Code: 0034A — $37.25 (effective November 2, 2021). DHHS also published its Provider Bulletin 21-21 – November 2021 COVID-19 Vaccines Updates, including COVID-19 booster doses and COVID-19 vaccinations for children. For questions, contact Medicaid.
Finally in Nebraska, the COVID rates have been added and been moved from the right-hand navigation list to the main list on the Department of Health and Human Service Medicaid Provider Rates and Fee Schedules website.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
North Carolina
In response to the U.S. Food and Drug Administration amended EUA for the Pfizer-BioNTech COVID-19 vaccine, authorizing the use of a single booster dose for administration to individuals 16 and 17 years of age at least six months after completion of primary vaccination with the Pfizer-BioNTech COVID-19 Vaccine and the CDC expanding the recommendation for boosters to include 16 and 17 year old, North Carolina has updated the Standing Order regarding vaccine administration.
Also in North Carolina, the Board of Pharmacy has issued new guidance concerning the application for Pharmacist-Technician Ratio of 1:6 or Greater.
Finally in North Carolina, please see Information regarding the Administration of Long Acting Injectables in Medicaid.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Ohio
The Ohio Department of Health (ODH) shared flu communications toolkits for healthcare providers to use in promoting flu vaccination for their patients during the 2021 – 2022 flu season. The Centers for Disease Control and Prevention (CDC) offers a NIVW digital toolkit featuring social media language and graphics, sample newsletter language, and printable resources. ODH posted a Flu Communications Toolkit that offers social media language and graphics and sample newsletter language around the importance of flu shots, in addition to flu and COVID-19 shots, as the best defense. Healthcare providers can monitor flu activity in Ohio, including county-level data, on the ODH Ohio Flu Activity webpage.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
South Carolina
Effective Jan. 1, 2022, the South Carolina Department of Health and Human Services (SCDHHS) will increase the reimbursement rates for the services and supplies related to: Incontinence Supplies, Department of Alcohol and Other Drug Abuse Services (DAODAS) and Autism Spectrum Disorder (ASD) Services. These changes will be reflected on the SCDHHS website by Jan. 1, 2022.
Providers with questions regarding this bulletin should contact the SCDHHS Provider Service Center at (888) 289-0709. The Provider Service Center's hours of operations are 7:30 a.m.-5 p.m. Monday-Thursday and 8:30 a.m.-5 p.m. Friday
Also in South Carolina, the Department of Insurance has provided a complaint form for pharmacies or interested parties to file complaints with the South Carolina Department of Insurance relating to pharmacy benefit manager (PBM) services. SC law requires pharmacies to make reasonable efforts to exhaust a PBM's internal appeal requirements prior to filing a complaint with the SCDOI. A copy of the appeal outcome must accompany the complaint submission.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Texas
The Health and Human Services Commission's (HHSC) Vendor Drug Program (VDP) semi-annual update of the Medicaid preferred drug list will occur on January 27, 2022. HHSC made the PDL changes based on recommendations made at the July and November 2021 Texas Drug Utilization Review Board meetings. Drug list decisions from those meetings are available.
Also in Texas, HHSC next Texas Vaccine Providers Webinar will be on Tuesday, December 14th at Noon Central. Register here.
Finally in Texas, in response to a request from the Texas State Board of Pharmacy, Gov. Greg Abbott (R) again temporarily suspended the requirement in §291.33(c)(1)(B)(iii) to have in-person contact for patient counseling in order to allow patient counseling to be performed by telephonic consultation. This remains in effect until March 31, 2022, or until the March 13, 2020, disaster declaration is lifted or expires, whichever is earlier.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Vermont
The Vermont Department of Financial Regulations has issued draft guidance for commercial insurance coverage of COVID-19 at-home rapid antigen testing. The Department contemplates requiring commercial health insurers to cover at-home rapid antigen testing listed as “preferred” by Vermont Medicaid without member cost sharing. Under the draft emergency rule, the tests would be fully covered when prescribed, in which case the claim would process exactly like any other prescription medication, or if the member submits a claim form. This guidance, once finalized, will be effective December 1, 2021.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
West Virginia
The Legislative Rule Making Review Committee adopted the PBM rule as currently written without any debate. The rule, based on the passage of HB 2263 or 2021, must now receive final approval by the Legislature during the 2022 session.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Wisconsin
This week Governor Tony Evers (D) signed into law three pro-pharmacy bills. In specific the three bills are the Pharmacist Provider Status – providing pharmacist’s reimbursement for any clinical care services covered under the Medicaid program (SB 255), Pharmacy Technician Registration- establishing the registration of pharmacy technicians (SB 300) and Remote Dispensing Sites (SB 308) which licenses these sites and provides more flexibilities for remote supervision of site pharmacists. These laws will be in effect as the supporting regulations are finalized in 2022.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Alabama
As Alabama Medicaid continues to monitor the COVID-19 national emergency in Alabama, Medicaid is adding procedure codes for coverage. Providers may submit claims for dates of service on or after the effective dates for each procedure code as listed here. Providers may find the reimbursement rates for the COVID-19 testing procedure codes on Medicaid’s website at www.Medicaid.Alabama.gov by selecting Fee Schedules under the Providers tab.
Also in Alabama, effective January 1, 2020, all newly registered technicians are required to complete a Board approved training program within six (6) months of the registration. Technicians with Board approved training completed, PTCB or CPhT certifications, or registered prior to January 1, 2020, will be reflected as compliant with the training requirement on the technicians’ Board of Pharmacy website profile.
To view this data:
- Go to albop.com
- Click Online Services
- Choose “Individual Verification” from the dropdown menu
- Input the technician registration number or name of the technician and enter the verification code displayed and click Search
- Identify the technician and choose the Print option to view the full license details including training information for technicians.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.